Higher rates of cancers associated with immunosuppression in ethnically minoritized men living with HIV highlight gaps in HIV diagnosis and treatment.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Hopes of ending the global HIV epidemic anytime soon are fading among health workers and scientists, who say new infections ...

A new Idaho law restricting public benefits for undocumented immigrants is facing a legal challenge. The ACLU of Idaho filed ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

Underscoring the global nature of HIV vaccine research, scientists with the CHAVD program helped design some of the immunogens, Bekker says.

Researchers say they've taken a major step toward finding a cure for HIV. As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding for the project, local media reported on Thursday. In January, the ...

In 1975, Arthur Ashe became the first black man to win Wimbledon in the gentlemen's singles draw. Fifty years later, HEAD released the Legacy Edition Arthur Ashe Competition Kit to celebrate his ...